L&K Biomed Ltd. (156100.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩6,800 (-0.58%) as of
Key statistics
- Market cap
- 151.99B
- Dividend yield
- 0.00%
- 52-week range
- 2,730.00 – 16,400.00
- Beta
- 0.69
- Revenue (TTM)
- 39.94B
- Profit margin
- 6.93%
- Volume
- 173.61k
About L&K Biomed Ltd.
L&K Biomed Ltd., engages in the manufacturing, production, and sales of medical devices in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior lumbar cage system. It also provides CastleLoc-C, an anterior cervical interbody fusion cage; CastleLoc-P, an anterior cervical plate system; CastleLoc-S, a posterior cervical fixation system; BluEX-C, a cervical expandable cage; AccelFix-S, a lumbar spinal fixation screw system; AccelFix-LP, a lumbar plate system; OpenLoc-L, a lumbar spinal fixation system; LnK Lumbar Peek Cages for posterior lumbar interbody fusion procedures; PathLoc-L, a MIS spinal system; AccelFix-MIS, a spinal fixation system; and PathLoc-SI sacroiliac fixation and fusion system that offers fusion and stabilization of the SI joint. In addition, the company offers CastleLoc Pectus bar system for the correction of pectus excavatum. L&K Biomed Ltd. was founded in 2008 and is headquartered in Yongin-si, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Yongin-si, South Korea
- Employees
- 105
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.